Better Choice to Announce Fourth Quarter and Full Year 2022 Financial Results on March 28, 2023
NEW YORK, March 07, 2023 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (AMEX: BTTR) (“Better Choice” or “the Company”), a...
NEW YORK, March 07, 2023 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (AMEX: BTTR) (“Better Choice” or “the Company”), a...
At the end of the orthodontic treatment, patients receive a set of custom-made retainers to protect and limit potential shift...
NEW YORK, March 07, 2023 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery,...
A SaaS Solution that Aligns Disparate Quality, Risk, and Custom Value-Based Initiatives Across Multiple Provider Points of CareBOWIE, Md., March...
ARLINGTON, Va. and COLUMBUS, Ohio, March 07, 2023 (GLOBE NEWSWIRE) -- Privia Health (Nasdaq: PRVA) and OhioHealth, a nationally recognized...
Presence in pharmaceutical industry hotbed allows Elevar to recruit top talent as it continues toward a commercial launch of cancer...
SAN DIEGO, March 07, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief...
Parties expect the merger to be completed promptly following the successful completion of the ongoing Tender OfferCAMBRIDGE, United Kingdom and...
SAN FRANCISCO and DALY CITY, Calif., March 07, 2023 (GLOBE NEWSWIRE) -- Adaptive Research, an integrated clinical trial site organization...
SCOTTSDALE, Ariz., March 07, 2023 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”) (Nasdaq: DERM), a commercial-stage biopharmaceutical company that...
BOSTON, March 07, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on developing novel...
Safety and Immunogenicity Examined in Phase 1 Trial of GPS plus Anti–PD-1 Nivolumab in Patients with WT1-Expressing Relapsed Ovarian Cancer...
SAN CLEMENTE, Calif., March 07, 2023 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive,...
Dosing of all patients was completed at the end of February No Serious Adverse Events (SAE’s) have been reported Phase 1 clinical...
GSAC Engineering Marks the First Phase of a Turnaround Plan to Drive its Corporate Growth StrategySTUART, Fla., March 07, 2023...
MIAMI, FL., March 07, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines...
Dynamic Digital Radiography Dynamic Digital Radiography is an enhanced X-ray technology that enables clinicians to analyze and quantify the dynamic...